Introduction: The initial symptoms of Alzheimer's disease (AD) include attention deficits, memory loss and deficiencies in topographic and spatial orientation. People with AD may have way-finding difficulties in driving due to the deterioration of their navigation ability. Although the use of the Global Positioning System (GPS) has been proven to be a useful aid for older people in driving, there is no evidence to suggest that the benefit could extend to drivers with AD. Aim: This study aims to investigate the effectiveness of the GPS in assisting drivers with mild AD in finding their destination safely. Method: Twenty-eight drivers with mild to very mild AD, diagnosed by a general practitioner or a psychogeriatrician, completed all clinical and psychometric assessments including the Mini Mental State Examination, Trail Making Test B and Doors and People Test. During the driving assessment, 3 driving trials with different settings (normal, visual-only and audio-only) of the GPS were administered to all participants. The participants were required to follow instructions from the GPS and perform a variety of driving tasks on a driving simulator. The driving performances of participants were assessed by criteria specific to AD drivers. The driving assessment criteria were first combined to form the overall driving performance score: a higher score indicated a better overall driving performance. The other outcome of this study was the success of participants to navigate to a predetermined destination. Results: The driving performance of participants was different among the 3 settings (F = 72.8, p < 0.001) and the pairwise comparison between the 3 settings was significant (p < 0.001). The driving performance score was highest in the audio-only setting (mean: 20.0, SD: 2.2), moderate in the normal setting (mean: 16.7, SD: 2.6) and lowest in the visual-only setting (mean: 14.3, SD: 3.3). When compared with the visual-only setting, drivers using the audio-only setting (OR: 37.2, 95% CI: 9.2-151.2) and normal setting (OR: 37.2, 95% CI: 4.8-286.9) were more likely to successfully find their destination (p < 0.05). Conclusion: This study has found that using single, simple auditory instructions with the absence of the visual output of the GPS could potentially help people with mild AD to improve their driving ability and reach their destination.

1.
Selander H, Lee HC, Johansson K, Falkmer T: Older drivers: on-road and off-road test results. Accident Anal Prevent 2011;43:1348-1354.
2.
Fuller R: Towards a general theory of driver behaviour. Accident Anal Prevent 2005;37:461-472.
3.
Man-Son-Hing M, Marshall SC, Molnar FJ, Wilson KG: Systematic review of driving risk and the efficacy of compensatory strategy in persons with dementia. J Am Geriatr Soc 2007;55:878-884.
4.
Access Economics: Projections of dementia prevalence and incidence in NSW: 2009-2050. Primary healthy and community partnership, 2009.
5.
World Health Organization: International Classification of Diseases, Version 10. Geneva, World Health Organization, 2007.
6.
Duchek J, Carr D, Hunt L, Roe C, Xiong C, Shah K, Morris JC: Longitudinal driving performance in early stage dementia of the Alzheimer type. J Am Geriatr Soc 2003;51:1342-1347.
7.
Uc EY, Rizzo M, Anderson SW, Dawson JD: Driver landmark and traffic sign identification early Alzheimer's disease. J Neurol Neurosurg Psychiatry 2005;76:764-768.
8.
Johansson K, Lundberg C: International consensus conference on dementia and driving: a brief report. Alzheimer Dis Assoc Disord 1994;11:62-69.
9.
Hunt LA, Aliana E, Brown AE, Gilman IP: Drivers with dementia and outcomes of becoming lost while driving. Am J Occup Ther 2010;64:225-232.
10.
Eby DW, Silverstein NM, Molnar LJ, LeBlanc D, Adler G: Driving behaviours in early stage dementia: a study using in-vehicle technology. Accident Anal Prevent 2011;2634:1-8.
11.
Martin AJ, Marottoli R, O'Neill D: Driving assessment for maintaining mobility and safety in drivers with dementia. Cochrane Database Syst Rev 2009;21:1-22.
12.
Freeman EE, Gange SJ, Munoz B, West SK: Driving status and risk of entry into long-term care in older adults. Am J Public Health 2006;96:1254.
13.
Marattoli RA, De Leon CFM, Glass TA, Williams CS, Cooney LM, Berkman LF: Consequences of driving cessation: decreased out-of-home activity levels. J Gerontol 2000;55:S334-S340.
14.
Ragland DR, Satariano WA, MacLeod KE: Driving cessation and depressive symptoms. J Gerontol 2005;60A:399-403.
15.
Bedard M, Molloy DW, Lever JA: Factors associated with motor vehicle crashes in cognitive impaired older adults. Alzheimer Disord Assoc Disord 1998;12:135-139.
16.
Uc EY, Rizzo M, Anderson SW, Dawson JD: Driver route-following and safety errors in early Alzheimer disease. Neurology 2004;63:832-837.
17.
Bryden KJ, Charlton JL, Oxley JA, Lowndes GJ: Self-reported wayfinding ability of older drivers. Accident Anal Prevent 2013;59:277-282.
18.
Dingus TA, Hulse MC, Mollenhauer MA, Fleischman RN, McGehee DV, Manakkal N: Effects of age, system experience, and navigation technique on driving with and advanced traveler information system. Hum Factors 1997;39:177-199.
19.
Zuin DOH, Boromei D, Lopez OL: Motor vehicle crashes and abnormal driving behaviours in patients with dementia in Mendoza, Argentina. Eur J Neurol 2002;9:29-34.
20.
Liu YC: Comparative study of the effects of auditory, visual, and multimodality displays on drivers' performance in advanced traveler information systems. Ergonomics 2001;44:425-442.
21.
Carr DB, Ott BR: The older adult driver with cognitive impairment ‘it's a very frustrating life'. Am J Occup Ther 2010;303:1632-2357.
22.
Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, Gamst A, Holtzman DM, Jagust WJ, Petersen RC, Snyder PJ, Carrillo MC, Thies B, Phelps CH: The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimer Dementia 2011;7:270-279.
23.
Petersen RC, Smith G, Waring S, Ivnik R, Tangalos E, Kokmen E: Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 1999;56:303-308.
24.
Baddeley AD, Emslie H, Nimmo-Smith I: Doors and People: A Test of Visual and Verbal Recall and Recognition. Bury St Edmunds, Thames Valley Test Co, 1994.
25.
Cox DJ, Quillian WC, Thorndike FP, Kovatchev BP, Hanna G: Evaluating driving performance of outpatients with Alzheimer's disease. Board Fam Pract 1998;11:264-271.
26.
Rizzo M, McGehee DV, Dawson JD, Anderson SN: Simulated car crashes at intersections in drivers with Alzheimer disease. Alzheimer Dis Assoc Disord 2001;15:10-20.
27.
Lee HC, Cameron D, Lee AH: Assessing the driving performance of older adult drivers: on road versus simulated driving. Accident Anal Prevent 2003;35:797-803.
28.
Folstein MF, Folstein SE, McHugh PR: Mini-mental state: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
29.
Dick JP, Gulloff RJ, Stewart A, Blackstock J, Bielawska C, Paul EA, Marsden CD: Mini-mental state examination in neurological patients. J Neurol Neurosurg Psychiatry 1984;47:496-499.
30.
Greene JD, Baddeley AD, Hodges JR: Analysis of the episodic memory deficit in early Alzheimer's disease: evidence from the doors and people test. Neuropsychologia 1996;34:537-551.
31.
Corrigan JD, Hinkeldey MS: Relationships between parts A and B of the Trail Making Test. J Clin Psychol 1987;43:402-409.
32.
Sanchez-Cubillo I, Perianez JA, Adrover-Roig D, Rodriguez-Sanchez JM, Rios-Lago M, Tirapu J, Barcelo F: Construct validity of the trail making test: role of task-switching, working memory, inhabitation/interference control and visuomotor abilities. J Neuropsychol Soc 2009;15:438-450.
33.
Ranzini M, Dehaene S, Piazzaa M, Hubbard EM: Neural mechanisms of attentional shifts due to irrelevant spatial and numerical cues. Neuropsychologia 2009;47:2615-2624.
34.
Psychology Software Tools: E-Prime 2: selected publications and other works. 2013. http://www.pstnet.com/eprimepublications.cfm.
35.
Lee HC, Lee AH, Cameron D, Li C: Using a driving simulator to identify older drivers at inflated risk of motor vehicle crashes. J Safety Res 2003;34:453-459.
36.
Cordell R, Lee HC, Granger A, Vieira B, Lee AH: Driving assessment in Parkinson's disease - a novel predictor of performance? Mov Disord 2008;23:1217-1222.
37.
Davis J, Lee HC, Falkmer T: An investigation into the impact of Parkinson's disease upon decision making ability and driving performance; in Dushanova J (ed): Diagnostics and Rehabilitation of Parkinson's Disease. Rijeka, Intech, 2011.
38.
Jensen BS, Skov MB, Thiruravichandran N: Studying driver attention and behaviour for three configurations of GPS navigation in real traffic driving. ACM Conf Hum Factors Comput Syst (CHI'10), Association for Computing Machinery, Aalborg, 2010.
39.
Dalton P, Agarwal P, Fraenkel N, Baichoo J, Masry A: Driving with navigational instructions: investigating user behaviour and performance. Accident Anal Prevent 2013;50:298-303.
40.
Parasuraman R, Nestor PG: Attention and driving skills in aging and Alzheimer's disease. Hum Factors 1991;33:539-557.
41.
Kennedy RS, Fowlkes JE: Duration and exposure to virtual environments: sickness curves during and across sessions. Presence 2000;9:463-472.
42.
Lee HC, Lee AH, Cameron D: Validation of a driving simulator by measuring the visual attention skill of older adult drivers. Am J Occup Ther 2003;57:324-328.
43.
Dahlman J, Sjors A, Ledin T, Falkmer T: Could sound be used as a strategy for reducing symptoms of perceived motion sickness? J Neuroeng Rehabil 2008;5:1-9.
44.
Cowings PS, Toscano WB, DeRoshia C, Tauso R: Effects of command and control vehicle operational environment on soldier health and performance. Hum Perf Extrem Environ 2001;5:66-91.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.